Summary: Whilst taking GLP-1 medicines, prioritise lean proteins, non-starchy vegetables, complex carbohydrates in moderate portions, and healthy fats, whilst limiting high-fat, ultra-processed, and sugary foods that may worsen side effects or undermine treatment goals
Possible (usually mild) side effects may include: Temporary discomfort or bruising at the injection site Mild headache or nausea in some individuals Rare irritation of the vein (phlebitis) Very rare allergic reactions (screened during pre-treatment assessment) Guided by international clinical standards (Cleveland Clinic, NHS protocols) Serious complications are uncommon when IV infusion therapy is delivered in a controlled clinical setting with appropriate patient selection and monitoring
We conduct an initial health assessment to determine if GLP-1 medication therapy is the right approach for you.
It functions as a dual GLP-1 and GIP receptor agonist , offering: Enhanced insulin secretion Delayed gastric emptying Appetite suppression Improved glycemic control Tirzepatide demonstrated impressive clinical outcomes in the SURMOUNT and SURPASS trials, with average weight loss of 15-22.5% and substantial A1C reductions